Results 1 to 10 of about 16,157 (149)

Colonic epithelial cathelicidin (LL‐37) expression intensity is associated with progression of colorectal cancer and presence of CD8+ T cell infiltrate [PDF]

open access: yesThe Journal of Pathology: Clinical Research, 2021
Colorectal cancer (CRC) remains a leading cause of cancer mortality. Here, we define the colonic epithelial expression of cathelicidin (LL‐37) in CRC. Cathelicidin exerts pleotropic effects including anti‐microbial and immunoregulatory functions. Genetic
Ross J Porter   +9 more
doaj   +10 more sources

Antifungal Activity of Human Cathelicidin LL-37, a Membrane Disrupting Peptide, by Triggering Oxidative Stress and Cell Cycle Arrest in Candida auris [PDF]

open access: yesJournal of Fungi, 2022
Candida auris, an evolving multidrug-resistant pathogenic yeast, is known for causing severe invasive infections associated with high mortality rates in hospitalized individuals. Distinct from other Candida species, C.
Irfan A. Rather   +3 more
doaj   +2 more sources

Epithelial-Immune Cell Crosstalk Determines the Activation of Immune Cells In Vitro by the Human Cathelicidin LL-37 at Low Physiological Concentrations [PDF]

open access: yesBiomolecules, 2023
The only human cathelicidin, LL-37, is a host defense antimicrobial peptide with antimicrobial activities against protozoans, fungi, Gram(+) and Gram(−) bacteria, and enveloped viruses.
Ivan V. Bogdanov   +5 more
doaj   +2 more sources

Cathelicidin LL-37 promotes EMT, migration and metastasis of hepatocellular carcinoma cells in vitro and mouse model [PDF]

open access: yesCell Adhesion & Migration, 2023
The effect of cathelicidin hCAP18/LL-37 in hepatocellular carcinoma (HCC) metastasis remains unclear. Here, we confirmed that LL-37 expression enhanced endothelial-mesenchymal transition (EMT), migration and invasion in HCC cells.
Huidan Zhang   +5 more
doaj   +2 more sources

Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus [PDF]

open access: yesJournal of Translational Autoimmunity, 2020
Cathelicidin LL-37 is an antimicrobial peptide that is synthesized by epithelial cells, neutrophils, or lymphocytes and act as an essential defense mechanism against bacterial, viral, or fungi infection of eukaryotic organisms.
Alejandro Moreno-Angarita   +2 more
doaj   +2 more sources

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model [PDF]

open access: yesAntibiotics, 2021
Background: LL-37 is the only human antimicrobial peptide that belongs to the cathelicidins. The aim of the study was to evaluate the efficacy of LL-37 in the management of MRSA-infected surgical wounds in mice. Methods: A wound on the back of adult male
Oriana Simonetti   +13 more
doaj   +2 more sources

Susceptibility of Pseudomonas aeruginosa biofilm to alpha-helical peptides: D-enantiomer of LL-37 [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology, 2011
Pseudomonas aeruginosa is a highly versatile opportunistic pathogen and its ability to produce biofilms is a direct impediment to the healing of wounds and recovery from infection.
Scott N. Dean   +2 more
doaj   +4 more sources

Citrullination Alters the Antiviral and Immunomodulatory Activities of the Human Cathelicidin LL-37 During Rhinovirus Infection [PDF]

open access: yesFrontiers in Immunology, 2020
Human rhinoviruses (HRV) are the most common cause of viral respiratory tract infections. While normally mild and self-limiting in healthy adults, HRV infections are associated with bronchiolitis in infants, pneumonia in immunocompromised patients, and ...
Víctor Casanova   +9 more
doaj   +2 more sources

Salivary Cathelicidin (LL-37) in Children and Adolescents Living with HIV [PDF]

open access: yesBiomedicine Hub
Introduction: Human cathelicidin LL-37 is a salivary antimicrobial peptide (AMP) with broad-spectrum activity against oral diseases, but few studies have assessed its role in children and adolescents living with HIV (CALHIV).
Ana Lucia Seminario   +8 more
doaj   +2 more sources

Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37

open access: yesPLoS ONE, 2011
The extensive world-wide morbidity and mortality caused by influenza A viruses highlights the need for new insights into the host immune response and novel treatment approaches. Cationic Host Defense Peptides (CHDP, also known as antimicrobial peptides),
Peter G Barlow, Ian A York, Jan Pohl
exaly   +3 more sources

Home - About - Disclaimer - Privacy